Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome

JAMA Dermatol. 2022 Dec 1;158(12):1449-1453. doi: 10.1001/jamadermatol.2022.3541.
No abstract available

Plain language summary

This case-control study uses single-institution data to explore risk factors associated with vancomycin drug reaction with eosinophilia and systemic systems (DRESS) syndrome.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Drug Hypersensitivity Syndrome* / diagnosis
  • Drug Hypersensitivity Syndrome* / drug therapy
  • Drug Hypersensitivity Syndrome* / etiology
  • Eosinophilia* / chemically induced
  • Eosinophilia* / complications
  • Eosinophilia* / diagnosis
  • Humans
  • Risk Factors
  • Vancomycin / adverse effects

Substances

  • Vancomycin
  • Anti-Bacterial Agents